Cite
Ito M, Hiwasa T, Oshima Y, et al. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer. Front Oncol. 2021;11:708039doi: 10.3389/fonc.2021.708039.
Ito, M., Hiwasa, T., Oshima, Y., Yajima, S., Suzuki, T., Nanami, T., Sumazaki, M., Shiratori, F., Funahashi, K., Li, S. Y., Iwadate, Y., Yamagata, H., Jambaljav, B., Takemoto, M., Yokote, K., Takizawa, H., & Shimada, H. (2021). Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer. Frontiers in oncology, 11708039. https://doi.org/10.3389/fonc.2021.708039
Ito, Masaaki, et al. "Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer." Frontiers in oncology vol. 11 (2021): 708039. doi: https://doi.org/10.3389/fonc.2021.708039
Ito M, Hiwasa T, Oshima Y, Yajima S, Suzuki T, Nanami T, Sumazaki M, Shiratori F, Funahashi K, Li SY, Iwadate Y, Yamagata H, Jambaljav B, Takemoto M, Yokote K, Takizawa H, Shimada H. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer. Front Oncol. 2021 Aug 24;11:708039. doi: 10.3389/fonc.2021.708039. eCollection 2021. PMID: 34504788; PMCID: PMC8421770.
Copy
Download .nbib